Related by context. Frequent words. (Click for all words.) 64 TRITON TIMI 64 randomized controlled clinical 63 placebo controlled clinical 63 Cardiovascular Risk 62 randomized clinical 61 Health Initiative WHI 60 RTOG 60 SWOG 60 prospective observational 60 substudy 60 multicenter clinical 60 SPIRIT III 60 dutasteride 60 Phase III randomized 59 multicenter randomized 59 subgroup analyzes 59 ClinicalTrials.gov 59 NHANES 59 retrospective cohort study 58 tesmilifene 58 placebo controlled randomized 58 Professionals Follow 58 blind randomized controlled 58 neoadjuvant 58 Arch Intern Med 58 Pivotal Phase III 58 Atherosclerosis Risk 58 PSA screening 57 randomized Phase III 57 placebo controlled trials 57 observational studies 57 End Results SEER 57 Postmenopausal Women 57 postmenopausal women 56 Breast Cancer Risk 56 Surveillance Epidemiology 56 Acute Myocardial Infarction 56 prospective cohort 56 anastrozole 56 Myocardial Infarction 56 meta analyzes 56 FDG PET 56 exemestane 56 multicenter 56 randomized controlled clinical trials 56 RCTs 56 Pivotal Phase 56 CAPRISA 56 randomized controlled trials 56 randomized trials 56 multicenter randomized double 56 J Clin Oncol 56 axitinib 56 meta analysis 56 nab paclitaxel 55 prostate biopsies 55 multicenter study 55 PCa 55 pre menopausal 55 multicentre 55 placebo controlled studies 55 randomized controlled 55 double blinded placebo 55 EORTC 55 Pivotal Trial 55 lipid lowering drugs 55 generalizability 55 Adjuvant 55 WHI 55 Eye Disease 55 Meta Analysis 55 Arch Neurol 55 post menopausal 55 Pharmacokinetic 55 plus progestin 55 postmenopausal breast cancer 55 Solid Tumors 54 rosuvastatin 54 Bladder Cancer 54 castration resistant prostate cancer 54 DSMB 54 abiraterone 54 randomized clinical trials 54 COPAXONE R 54 Heart Failure Patients 54 secondary efficacy endpoints 54 tumor recurrence 54 candesartan 54 recurrent ovarian cancer 54 Randomized Controlled Trial 54 randomized placebo controlled 54 premenopausal women 54 prospective randomized controlled 54 Diabetic Retinopathy 54 Medical Expenditure Panel 53 Rosuvastatin 53 Mylotarg 53 Hormone Therapy 53 placebo controlled 53 prostate specific antigen 53 evaluable patients